Pet Supplement Quality: The Label-to-Bowl Standard

Walk down a pet-store aisle—or scroll through supplements online—and the same claims appear again and again.

Premium ingredients. Science-backed. Veterinarian-formulated. Human grade. Third-party tested.

These phrases are not necessarily false. The problem is that they are incomplete. A carefully designed product and a poorly substantiated one can be described in almost exactly the same language.

A label shows what a company declares. It cannot tell you whether the dose fits the research, the supplier delivered the right material, the finished batch matched the formula, or fragile ingredients will last until the final serving.

Those answers come from study designs, formulation decisions, supplier records, manufacturing controls, stability programs, and laboratory reports. They are less visible than the label and packaging, but they are what make the product possible to evaluate.

Small product surveys cannot estimate the failure rate of the whole category, but they show why product-specific verification matters. A 2009 analysis found 10 of 11 taurine products and all 10 carnitine products within 10 percent of their label amounts. That is reassuring.^[1] A 2025 analysis of 11 fish-oil supplements for dogs found substantial variation and six instances in which measured EPA, DHA, or both missed label claims by more than 5 percent.^[2] An assessment of six companion-animal kefir products found discrepancies in both microbial quantities and the organisms named on their labels.^[3]

Taken together, these studies do not show that pet supplements are broadly trustworthy or broadly unreliable. They support a product- and batch-specific evaluation:

Quality cannot be inferred from the category, the ingredient, or the packaging. It has to be demonstrated by the particular product—and, where possible, by the particular batch.

One piece of U.S. context matters: “pet supplement” is a marketplace term, not a separate FDA regulatory category. FDA regulates products sold for animals as animal food or animal drugs depending on their ingredients and intended use.^[4] A supplement-style package is not, by itself, evidence that FDA reviewed or approved the finished product.

Scope note: This guide focuses on products marketed in the United States. Requirements vary by product, intended use, and jurisdiction.

Transparency note: La Petite Labs develops and sells pet supplements. We publish these criteria so pet parents, veterinarians, and retailers can apply the same scrutiny to our products that they apply to any other brand.

Most pet parents compare what they can readily see: ingredient lists, reviews, price, packaging, and marketing claims. A stronger evaluation goes further. It follows the product from its original promise to the serving the animal actually consumes.

The Label-to-Bowl Standard: what pet supplement quality actually requires

At La Petite Labs, we call this the Label-to-Bowl Standard: seven links that should hold from a product’s scientific premise to the serving an animal actually consumes.

In short: A credible supplement keeps all seven links intact. Good science cannot rescue a token dose. Careful formulation cannot rescue a poorly controlled batch. And a perfect COA cannot make a product right for every animal.

Science can justify the promise. The rest of the product system determines whether that promise survives the journey to the bowl.

Each link answers its own question: Could the formula help? Was it made as intended? Will important qualities hold through expiration? Is it right for this pet? Research, production records and testing, stability evidence, and veterinary judgment answer different parts. None can stand in for the others.

Ingredient research cannot verify a production batch. A COA cannot establish clinical efficacy. A manufacturing certification cannot determine whether a supplement is right for your pet.

1. Science: Does the evidence match the claim?

You can find research on almost every popular supplement ingredient. What matters is how closely that research matches the product’s promise.

Consider a supplement marketed for healthy aging in dogs. A cell study may reveal an interesting mechanism. A human trial may make the idea more plausible. A study in dogs at a comparable dose is more directly relevant. A well-designed trial of the complete formula comes closest to supporting a product-specific outcome. Each can be useful, but they are not interchangeable.

To understand how well the science fits the claim, look across seven dimensions:

1. Species: Were dogs, cats, humans, rodents, cells, or another model studied?
2. Population: Were the subjects healthy, aging, deficient, or living with a specific condition?
3. Intervention: Was the same ingredient, strain, extract, combination, or complete formula studied?
4. Form: Was the chemical or physical form comparable?
5. Amount: Does the daily serving resemble the amount used in the research?
6. Duration: Was the intervention studied for a period relevant to the promise?
7. Outcome: Did the research measure the advertised result, or only a distant biomarker or mechanism?

The closer the match, the more directly the evidence can support the claim.

A trial of the complete formula offers the strongest product-specific evidence, but it is not the only basis for a responsibly framed claim. Species-relevant ingredient research, nutritional evidence, established physiological roles, and a coherent rationale may support narrower language. The stronger and more product-specific the claim, the more closely the evidence should match the marketed formula, dose, population, and use.^[5]

“Contains clinically studied ingredients” is not the same statement as “this formula was clinically studied.”

Look for a research page that maps claims to studies, shows whether the species, form, amount, and outcome match, and distinguishes promising evidence from product-specific proof. Research can identify what might work. It cannot tell you whether a manufactured serving contains enough of the right material.

2. Formulation and dosage: Does the daily serving make sense?

Imagine a senior-pet formula with 25 fashionable ingredients packed into one small proprietary blend.

Blueberry, CoQ10, mushrooms, glucosamine, probiotics, turmeric, resveratrol, green-lipped mussel, and several vitamins all appear prominently. Nothing on that list is automatically irrational. Yet without individual amounts, the customer cannot tell which ingredients carry the formula, which are present in meaningful quantities, and which function mainly as decoration.

Every added ingredient raises more questions: What is it for? Which form is used? How much is included? Will it remain stable? Can its amount or identity be verified?

Start with the daily serving. If an ingredient appears prominently on the front of the box, the amount your pet receives should be easy to find. An ingredient list without quantities tells you what is declared to be present, but not whether the amount is plausible, trivial, or potentially excessive.

Form matters, too. “1,000 mg fish oil” does not tell you how much EPA and DHA the product supplies. A probiotic species without an identified strain may omit an important part of the evidence. A generic botanical powder is not necessarily equivalent to a standardized extract used in research. A mineral name may not reveal its chemical form or elemental amount.

A proprietary blend is not proof of poor quality. But when individual amounts are withheld, customers and veterinarians cannot fully compare the formula with the research, assess overlap with other supplements, or judge whether promoted ingredients are present in sensible quantities.

There is no universal “effective dose” for every pet-wellness ingredient. Where no authoritative dose exists, a responsible formulator should explain why the amount makes sense for the species, body weight, ingredient form, and intended use—not hide behind a “clinically dosed” badge.

Cross-species products require particular care. Dogs and cats share many physiological systems, but they are not nutritionally interchangeable. A formula intended for both should explain why its ingredients, directions, and cautions make sense for each.

3. Ingredient sourcing: Can every ingredient be identified and traced?

An ingredient name is a starting point, not proof of what arrived at the factory.

Materials sold under the same familiar name can differ in species, strain, concentration, plant part, extraction, freshness, purity, or chemical form. That is why sound sourcing begins with written specifications and qualified suppliers—not faith in an ingredient’s reputation.

The relevant specifications depend on the ingredient:

• A fish oil may need defined EPA and DHA content, oxidation limits, and relevant contaminant controls.
• A probiotic may require strain identity, viable count, and conditions that preserve viability.
• A botanical may require confirmation of species, plant part, extraction, and marker compounds.
• A mineral may require the correct chemical form and elemental amount.

A responsible input system defines what the manufacturer will accept, links each raw-material lot to its supplier and records, and preserves that traceability through the finished production batch. Depending on the material and risk, this may involve identity testing, supplier certificates, confirmatory analysis, audits, or other qualification work.

A supplier COA can be valuable. But it describes the ingredient lot on that document—not the finished supplement in a customer’s hand.

An ingredient must also be suitable for its intended animal use. Use in human foods or supplements does not automatically make the same material appropriate—or lawfully used for the same purpose—in dogs or cats.^[6]

Country of origin is relevant, but not decisive.

A domestic material can be poorly documented; an imported one can be traceable, responsibly produced, and rigorously tested. Manufacturing location alone does not reveal who supplied each ingredient, how those suppliers were qualified, or what the company verified.

The better question is not simply Where did it come from? but What was specified, verified, and traced?

A verified ingredient is still only an input. It must survive weighing, blending, transfer, and packaging without losing identity or uniformity.

4. Manufacturing: Is the process controlled?

A factory’s job is to turn a formula on paper into a consistent product. That requires the right materials in the right amounts, a uniform blend, controls against contamination and mix-ups, correct packaging, and records linking every ingredient lot to every finished lot.

When something departs from the plan, there should be a documented investigation. When a complaint arrives, the package should be traceable to the finished lot and its ingredients. Manufacturing controls are what make the process repeatable.

In the United States, covered animal-food facilities must follow applicable current good manufacturing practice requirements, and many are subject to hazard analysis and preventive controls.^[7] These are meaningful requirements. They are not clinical proof and do not mean that every active was tested in every batch.

“FDA-registered facility” is also routinely misunderstood. Food-facility registration is an administrative requirement for covered facilities. It is not FDA approval, certification, or endorsement of the facility or its products.^[8]

Voluntary audits and quality seals can add useful information, but only within the scope of the program. A quality-system audit does not prove that the product produces a benefit, that every active amount was measured, or that stability has been established through expiration.

When reviewing a certification or facility claim, ask what was actually controlled, audited, or verified—and under which rule or standard.

Process controls are designed to prevent mistakes. Finished-batch testing asks whether the process delivered what it was supposed to.

Quality cannot be tested into a product after a poorly controlled process.

5. Finished-product testing: What does a COA verify?

Raw-material controls are essential. But supplier qualification, specifications, and input testing cannot answer the whole question.

Weighing, blending, heat, moisture, transfer, segregation, measurement error, and packaging can all affect the finished product. A formula may be excellent on paper and still emerge from production with an active content outside specification, a uniformity problem, excess moisture, oxidation, or another issue the raw-material records could not reveal.

What a COA actually is

A Certificate of Analysis, or COA, is a record of specified test results for an identified material or product. It should identify the sample and, where applicable, the lot or batch it represents. A COA may cover a raw ingredient, an in-process material, or a finished product; its data may come from in-house testing, an outside laboratory, or both.

A COA reports specified tests performed on an identified sample; its scope does not extend beyond those tests and that sample.

A report describes the sample that reached the laboratory. How well that sample represents the wider lot depends on the sampling plan. And an outside-laboratory result does not necessarily mean the laboratory chose or collected the sample; that requires separate sampling and chain-of-custody evidence.

The phrase “third-party tested” answers only one preliminary question: at least some testing was reportedly performed outside the brand or manufacturer. It does not tell you which sample was tested, whether it was raw material or finished product, which lot was involved, what the laboratory measured, what it found, or whether the result met a defined limit.

Testing should fit the formula

There is no universal COA panel that proves every pet supplement is “safe” or “high quality.”

A credible testing plan reflects the formula, ingredient risks, dosage form, manufacturing process, and claims. Depending on the product, it may include:

• Identity: Is the tested material or analyte what it is claimed to be?
• Selected active content: Did specified nutrients, compounds, fatty acids, marker compounds, or viable organisms meet defined criteria?
• Microbial quality: Were relevant organisms or microbial counts assessed?
• Elemental contaminants: Were substances such as lead, arsenic, cadmium, or mercury measured against appropriate limits?
• Other relevant risks: Were oxidation, mycotoxins, pesticides, residual solvents, selected adulterants, or allergens considered where appropriate?
• Physical qualities: Were fill weight, appearance, moisture, water activity, disintegration, or uniformity relevant to release?

A “pass” is only as useful as the limit behind it. A label minimum, an internal target range, and a risk-based contaminant maximum answer different questions. The report should say which kind of limit it uses and where that limit came from.

Contaminant numbers also need context. A concentration such as parts per million is not the same as the amount an animal consumes each day. The maximum daily serving, species, body weight, duration of use, and background diet all affect exposure. FDA has not set general action levels or tolerances for heavy metals in animal food and may assess concerns case by case, so a company-created “pass” limit should disclose its basis.^[9]

Not every compound in a complex formula can be measured directly in the finished product with equal reliability. A suitable validated method may not exist for that ingredient in that particular matrix. Some ingredients are instead controlled through input specifications, manufacturing controls, marker compounds, or testing at another stage.

A testing disclosure should state exactly what was tested, where it was tested, and what the result can establish.

Comparing two testing disclosures

Imagine turning over a supplement box, finding the lot number, and opening the company’s testing evidence.

The first report says only:

Salmonella: Not detected.

That result is useful. It tells you something about the reported sample and method. It does not tell you whether the featured active ingredients were present at their declared amounts, whether heavy metals were assessed, whether identity was confirmed, or whether the product remains stable through expiration.

A second report matches the finished product and lot number. It identifies the sample type and laboratory, lists selected actives, microbes, and contaminants, shows actual results and units, and places those results beside the applicable limits.

Both brands may say “third-party tested.” The customer can inspect far more in the second case.

The 60-second COA check

You do not need to understand every analytical method to learn something useful from a COA. Start with five questions:

1. Does it match?
   Do the product name, dosage form, and lot number match the package?

2. What was sampled?
   Was the report for a raw ingredient, an in-process material, or the finished product?

3. What was tested?
   Which active compounds, organisms, contaminants, markers, or physical qualities were included?

4. What did the laboratory find?
   Are the actual results, units, and applicable limits shown?

5. Who performed the work—and when?
   Are the laboratory, relevant dates, and final report status visible?

Method information can matter when a test is unusual, a matrix is difficult, or a result is close to a limit. ISO/IEC 17025 accreditation can add confidence in laboratory competence, but it applies to a defined scope. When that distinction matters, check whether the relevant test or activity falls within it.^[10]

When a report says “not detected,” look for the method’s reporting, detection, or quantitation threshold where relevant. “Not detected” generally means the analyte was not found at or above that threshold. It does not mean absolute zero.

Four levels of testing transparency

This progression ranks transparency—not laboratory skill or the quality of an unseen internal system. A company can maintain serious controls without publishing every record. Public lot access simply lets customers, veterinarians, retailers, and other reviewers inspect more of the evidence themselves.

What a COA cannot prove

Even an excellent finished-product COA cannot, by itself, establish:

• That the formula produces a clinical benefit
• That every ingredient or possible contaminant was tested
• That every unit in a lot is perfectly identical
• That tested qualities will remain within specification through expiration
• That the product is appropriate for a particular pet
• That the animal will consume it consistently

These are not failures of the COA. They are the proper limits of analytical evidence.

6. Stability: Will quality hold through expiration?

Ingredients can change in storage. Oils oxidize; probiotic counts fall; vitamins and plant compounds degrade; powders absorb moisture or separate. Heat, oxygen, light, packaging, time, and repeated opening all affect what reaches the final serving.

A passing release test, therefore, does not guarantee the same result near expiration.

An expiration or best-by date should be supported for the finished formula in the packaging customers actually receive. A sound stability program considers likely storage conditions, the ingredients tied to key claims, relevant physical changes, and—when it matters—the period after opening.

Real-time studies are the most direct because they observe the product across its intended shelf life. Accelerated studies use harsher conditions to model change more quickly. They can guide development and ongoing decisions, but only when the model fits the formula.

Manufacturers sometimes add extra amounts of unstable nutrients so the label minimum is still met near expiration. Any such overage should be scientifically justified, legally compliant, within appropriate safety limits, and supported by stability data.

For a probiotic, choosing the right strain is one question. Confirming the live count at manufacture is another. Preserving that count through shipping, storage, opening, and expiration is the third.

7. Individual suitability: Will the right dose reach the pet?

The dose an animal actually receives depends on clear directions, a sensible serving for its weight, accurate measurement, palatability, tolerance, and owner consistency. Even a well-designed powder cannot provide its intended support if the animal does not consume it.

This is where customer reviews add real value. Patterns can flag recurring issues involving taste, texture, convenience, packaging, gastrointestinal complaints, and adherence. Reviews cannot establish safety or tolerability, or verify ingredient identity, active content, manufacturing controls, or clinical efficacy.

Batch quality and individual safety are different questions. A well-made supplement can still be wrong for a particular animal because of species, life stage, disease, medications, diet, allergies, planned surgery, pregnancy, or overlap with other supplements. A COA may address specified microbial, contaminant, identity, or active-content questions, but it cannot determine whether the product is right for one dog or cat.

Ask a veterinarian before use when an animal has a medical condition, takes medication, is pregnant or nursing, is very young, has a history of adverse reactions, or receives several supplements at once.

If you suspect a reaction, stop the supplement and contact your veterinarian. Seek urgent care for severe symptoms. Keep the original package and lot number; they help the company, veterinarian, and FDA identify the product and investigate the report.^[11]

What familiar quality claims really mean

Familiar quality claims usually describe one link in the chain, not the whole product. Read each within its exact scope.

The 10-question pet supplement quality checklist

1. What precisely is this product intended to support?
2. Does the research match the species, ingredient form, amount, duration, and advertised outcome?
3. Are individual active amounts and important forms disclosed per recommended daily serving?
4. Does the serving logic make sense for the intended species and body weight?
5. Can the company explain how it qualifies and traces its ingredients?
6. Are its manufacturing controls, certifications, and their scopes explained clearly?
7. Was a representative sample from the finished production lot tested—not only selected raw materials?
8. Can the published report be matched to the lot number on the package, with actual results and limits?
9. What supports quality through the stated shelf life?
10. Are cautions, situations that warrant veterinary guidance, and adverse-event contact information easy to find?

No answer proves quality by itself. Look for a coherent pattern across all ten.

Why La Petite Labs built a lot-number COA lookup

A standard matters only if the company proposing it is willing to be judged by it. We expect customers, veterinarians, and retailers to apply this framework to La Petite Labs, too.

The Label-to-Bowl Standard is our public evaluation framework; it is not a certification or a substitute for regulatory requirements. LPL-01 is the internal product standard we apply to our own formulas.

Our Evidence Library distinguishes ingredient and mechanistic evidence from proof about a finished product. Our LPL-01 standard describes the formulation principles behind our systems. Our Quality & Testing standards describe our manufacturing and verification approach. And our Editorial Guidelines explain how we source, review, and update educational content.

Beginning with covered production lots as records are published, the La Petite Labs COA Lookup will let customers match the number on a package to its associated testing record: what was tested, what the laboratory found, and whether the reported results met the stated limits. These records make the testing claim inspectable, but they do not establish that a supplement will work for every pet.

For a complementary veterinary perspective, see Dr. Sarah Wooten’s Seven Failure Modes of Pet Supplements.

The standard the category should move toward

A serious quality standard should survive seven handoffs: from claim to evidence, evidence to formula, formula to ingredients, ingredients to production, production to finished-batch results, results to shelf life, and finally to the animal.

That is what the Label-to-Bowl Standard is designed to test. No badge, laboratory result, manufacturing location, or celebrated ingredient can stand in for the entire chain.

Pet parents should not need access to every internal record or a degree in analytical chemistry. But they should be able to see how a claim connects to a formula, how that formula connects to a finished batch, and what the available evidence can—and cannot—show.

The animal cannot read a marketing claim, question a proprietary blend, inspect a laboratory report, or enter a lot number into a lookup. That responsibility belongs to the people who formulate, manufacture, recommend, sell, and choose the product.

Frequently asked questions

What is the most important sign of a high-quality pet supplement?

No single sign is sufficient. Look for a coherent formula with disclosed amounts, relevant research, traceable ingredients, credible manufacturing controls, appropriate finished-product testing, supported shelf life, and directions suited to the intended animal.

Are pet supplements FDA-approved?

Not as a special “dietary supplement” category. FDA regulates products sold for animals as animal food or animal drugs depending on their ingredients and intended use. Food-facility registration is not product approval; an FDA-approved animal drug is a different regulatory status.^[4][8]

What should a pet supplement COA show?

A useful COA identifies the product and dosage form, sample type, production lot, tests, numerical results, units, acceptance limits, laboratory, relevant dates, and final report status. It should make clear what met specification—and what was not tested.

Does a COA prove that a pet supplement is safe?

No. A COA can provide evidence about the specific risks and qualities included in its testing panel for the reported sample. It does not test every possible risk, establish universal safety, or determine whether the product is appropriate for an individual pet.

Does a COA prove that a supplement works?

No. A COA can show reported analytical results for specified tests. Evidence of a clinical or nutritional benefit requires appropriate research. Analytical conformity and efficacy are different questions.

Does “third-party tested” mean the finished product was tested?

Not necessarily. The phrase may refer to a raw ingredient, an in-process material, or a finished product. The report should identify the sample type, product, lot, tests, results, and limits.

Are proprietary blends always low quality?

No. But undisclosed individual amounts prevent customers and veterinarians from fully assessing dose rationale, comparison with research, and overlap with other products.

Is a supplement made in the USA automatically better?

No. Manufacturing location can be useful context, but it does not establish ingredient verification, manufacturing consistency, finished-batch results, shelf life, or effectiveness.

What should I do if my pet reacts to a supplement?

Stop the supplement and contact your veterinarian. Seek urgent care for severe symptoms. Keep the original package and lot number, and report the suspected problem to the company and, where appropriate, FDA.^[11]

Sources and further reading

1. Bragg RR, Freeman LM, Fascetti AJ, Yu Z. Composition, disintegrative properties, and labeling compliance of commercially available taurine and carnitine dietary products. J Am Vet Med Assoc. 2009;234(2):209–213. doi:10.2460/javma.234.2.209.
2. Ober LR, Larsen JA, Hoffman LE, Puschner B, Fascetti AJ. Analysis of selected nutrients and contaminants in fish oil supplements for dogs. Topics in Companion Animal Medicine. 2025;65:100949. doi:10.1016/j.tcam.2025.100949.
3. Metras BN, Holle MJ, Parker VJ, Miller MJ, Swanson KS. Assessment of commercial companion animal kefir products for label accuracy of microbial composition and quantity. J Anim Sci. 2020;98(9):skaa301. doi:10.1093/jas/skaa301.
4. U.S. Food and Drug Administration. FDA’s Regulation of Pet Food.
5. U.S. Federal Trade Commission. Health Products Compliance Guidance.
6. U.S. Food and Drug Administration. Animal Food Ingredients.
7. U.S. Food and Drug Administration. FSMA Final Rule for Preventive Controls for Animal Food.
8. U.S. Food and Drug Administration. Questions and Answers Regarding Food Facility Registration. Seventh edition. August 2018.
9. U.S. Food and Drug Administration, Center for Veterinary Medicine. Report on Heavy Metals in Animal Food. October 2019.
10. International Organization for Standardization. ISO/IEC 17025—Testing and Calibration Laboratories.
11. U.S. Food and Drug Administration. How to Report a Pet Food Complaint.
12. Association of American Feed Control Officials. Human Grade Pet & Specialty Pet Food Claim: Frequently Asked Questions. September 2024.
13. U.S. Federal Trade Commission. Complying with the Made in USA Standard.
14. National Animal Supplement Council. NASC Quality Seal.